Douglas Love

Douglas Love

Chief Executive Officer chez ANNEXON, INC.

Fortune : 1 M $ au 31/03/2024

56 ans
Health Technology
Consumer Services
Commercial Services

Profil

Douglas Love's current job(s) include being the President, Chief Executive Officer & Director at Annexon, Inc. since 2014 and also holding the same position at Annexon Biosciences, Inc.Mr. Love's former job(s) include working as a Corporate Counsel at Amgen, Inc. from 1999 to 2001, as a Corporate Counsel at Genentech, Inc. from 2001 to 2006, as the Head-Operations & Strategic Alliances at Elan Pharmaceuticals LLC from 2008 to 2013, and as an Associate at Orrick, Herrington & Sutcliffe LLP from 1996 to 1999.
Mr. Love completed his undergraduate degree at the University of Southern California in 1991 and obtained his graduate degree from Mcgeorge School of Law in 1995.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
16/02/2024 196 121 ( 0,22% ) 1 M $ 31/03/2024

Postes actifs de Douglas Love

SociétésPosteDébut
ANNEXON, INC. Chief Executive Officer 01/12/2014
Annexon Biosciences, Inc. Chief Executive Officer -
Tous les postes actifs de Douglas Love

Anciens postes connus de Douglas Love

SociétésPosteFin
Corporate Officer/Principal 01/04/2013
General Counsel 01/01/2006
AMGEN INC. General Counsel 01/01/2001
Corporate Officer/Principal 01/01/1999
Voir l'expérience en détail de Douglas Love

Formation de Douglas Love

University of Southern California Undergraduate Degree
Mcgeorge School of Law Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Douglas Love

Relations

100 +

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
AMGEN INC.

Health Technology

ANNEXON, INC.

Health Technology

Entreprise privées4

Health Technology

Health Technology

Commercial Services

Annexon Biosciences, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Douglas Love